96 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00570 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 3 µM |
| dbacp00571 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 9 µM |
| dbacp00572 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp00618 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 4 µM |
| dbacp00619 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 7 µM |
| dbacp00620 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp02113 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 26 µM |
| dbacp02114 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 32 µM |
| dbacp02115 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 31 µM |
| dbacp02116 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02117 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02118 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02119 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 38 µM |
| dbacp02120 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 26 µM |
| dbacp02121 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 23 µM |
| dbacp02122 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 79 µM |
| dbacp02123 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 74 µM |
| dbacp02124 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 62 µM |
| dbacp02125 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 54 µM |
| dbacp02126 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 31 µM |
| dbacp02127 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 25 µM |
| dbacp02128 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 100 µM |
| dbacp02129 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 81 µM |
| dbacp02130 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 67 µM |
| dbacp02131 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 47 µM |
| dbacp02132 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 21 µM |
| dbacp02133 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 27 µM |
| dbacp02134 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02135 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02136 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02137 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 83 µM |
| dbacp02138 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 54 µM |
| dbacp02139 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 30 µM |
| dbacp02140 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02141 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : <100 µM |
| dbacp02142 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : <100 µM |
| dbacp02235 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 15.8 µM |
| dbacp02236 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 16.1 µM |
| dbacp02237 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 15.8 µM |
| dbacp02238 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 20 µM |
| dbacp02239 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 20 µM |
| dbacp02240 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 25 µM |
| dbacp02253 | CA-ME | KWKLFKKIGIGAVLKVLTTG | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 32.2 µM |
| dbacp02254 | CA-ME | KWKLFKKIGIGAVLKVLTTG | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 28.6 µM |
| dbacp02255 | CA-ME | KWKLFKKIGIGAVLKVLTTG | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 28.6 µM |
| dbacp04730 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 9.5 µM |
| dbacp04731 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 12 µM |
| dbacp04732 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 6 µM |
| dbacp04733 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 11 µM |
| dbacp04734 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 11 µM |
| dbacp04735 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 7 µM |
| dbacp04736 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 17 µM |
| dbacp04737 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 17 µM |
| dbacp04738 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 11 µM |
| dbacp04739 | N-3L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04740 | N-3L | KWFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 4 µM |
| dbacp04741 | N-3L | KWFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 4.2 µM |
| dbacp04742 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 32 µM |
| dbacp04743 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 23 µM |
| dbacp04744 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 24 µM |
| dbacp04745 | N-4L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04746 | N-4L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 6 µM |
| dbacp04747 | N-4L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3 µM |
| dbacp04748 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : < 100 µM |
| dbacp04749 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : < 100 µM |
| dbacp04750 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : < 100 µM |
| dbacp04751 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 :17 µM |
| dbacp04752 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 :14 µM |
| dbacp04753 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 :10 µM |
| dbacp05032 | P1 | KWKLFKKIGIGAVLKVLKKG | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 :3.4 µM |
| dbacp05033 | P1 | KWKLFKKIGIGAVLKVLKKG | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 :3.5 µM |
| dbacp05034 | P1 | KWKLFKKIGIGAVLKVLKKG | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 :4.5 µM |
| dbacp05048 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 8 µM |
| dbacp05049 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | Jurkat | Blood cancer | IC50 : 4 µM |
| dbacp05050 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 3.5 µM |
| dbacp05052 | P2 | KWKLFKKIGIGKFLHSATTF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 36.2 µM |
| dbacp05053 | P2 | KWKLFKKIGIGKFLHSATTF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 37.9 µM |
| dbacp05054 | P2 | KWKLFKKIGIGKFLHSATTF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 47.7 µM |
| dbacp05058 | P3 | KWKLFKKIGIGAFLHSAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 9.3 µM |
| dbacp05059 | P3 | KWKLFKKIGIGAFLHSAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 9.3 µM |
| dbacp05060 | P3 | KWKLFKKIGIGAFLHSAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 10.9 µM |
| dbacp05072 | P4 | KWKLFKKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 1.9 µM |
| dbacp05073 | P4 | KWKLFKKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 1.3 µM |
| dbacp05074 | P4 | KWKLFKKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 2.8 µM |
| dbacp05075 | P5 | KWKLFKKIGIGAFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 2.9 µM |
| dbacp05076 | P5 | KWKLFKKIGIGAFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 2.9 µM |
| dbacp05077 | P5 | KWKLFKKIGIGAFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 3.2 µM |
| dbacp05086 | P6 | KWKLFKKIGIGKFKLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 1.7 µM |
| dbacp05087 | P6 | KWKLFKKIGIGKFKLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 2 µM |
| dbacp05088 | P6 | KWKLFKKIGIGKFKLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 3.1 µM |
| dbacp05095 | P7 | KWKLFAKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 3.1 µM |
| dbacp05096 | P7 | KWKLFAKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 2.4 µM |
| dbacp05097 | P7 | KWKLFAKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 2.4 µM |
| dbacp05099 | P8 | KWKKFLKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis | MTT/MTS assay | NCI-H69 | Lung cancer | IC50 : 2.6 µM |
| dbacp05100 | P8 | KWKKFLKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H128 | Lung cancer | IC50 : 2.3 µM |
| dbacp05101 | P8 | KWKKFLKIGIGKFLHLAKKF | Ceropin A-African clawed frog | Apoptosis inducing | MTT/MTS assay | NCI-H146 | Lung cancer | IC50 : 1.8 µM |